found
eip
known
interact
virus
also
predict
broadspectrum
essenti
host
factor
valid
essenti
infect
vitro
eip
interact
protein
like
target
antiinflammatori
neurolog
drug
indic
potenti
serv
hostori
antivir
target
thu
use
connect
map
find
drug
inhibit
eip
express
predict
tanespimycin
candid
demonstr
antivir
effici
vitro
find
provid
first
systemat
identif
protein
interact
analysi
eip
protein
characterist
demonstr
valu
develop
hostori
antivir
therapi
enteroviru
picornavirida
famili
one
predomin
caus
human
hand
foot
mouth
diseas
hfmd
especi
across
asiapacif
region
although
hfmd
caus
infect
mostli
lead
mild
symptom
diseas
may
complic
seriou
symptom
poliomyelitislik
paralysi
encephalomyel
myocard
neonat
sepsi
result
sever
even
fatal
consequ
infect
children
year
age
absenc
efficaci
therapi
sever
infect
prevent
vaccin
outbreak
recurr
epidem
major
threat
public
health
caus
widespread
panic
epidem
genom
singlestrand
posit
rna
approxim
kb
size
contain
three
encod
region
region
encod
four
structur
protein
extern
intern
wherea
region
encod
seven
nonstructur
protein
encod
region
encod
region
phylogenet
analysi
base
gene
divid
viru
three
independ
lineag
design
b
c
genotyp
b
c
still
circul
worldwid
focus
genotyp
c
continu
circul
throughout
china
rapid
progress
systemat
hostviru
interact
research
provid
new
data
clinic
applic
networkbas
model
viru
infect
date
littl
progress
made
viru
infect
therapi
tamiflu
influenza
viru
selfprotein
neuraminidasetarget
drug
limit
progress
attribut
rapid
mutat
viral
genom
lead
virustarget
drug
lose
effect
new
variant
concomit
rapid
progress
systemat
attempt
collect
hostviru
physic
interact
data
protein
annot
rna
interfer
rnai
data
function
data
recent
wit
chang
perspect
antivir
drug
research
drug
target
essenti
host
factor
virus
may
broadspectrum
mutantinsensit
common
method
identifi
essenti
host
factor
virus
knock
host
gene
determin
whether
viru
infect
control
howev
approach
practic
everi
viru
due
low
repeat
rate
high
cost
virushost
proteinprotein
interactom
also
provid
potenti
host
target
antivir
research
yeast
twohybrid
system
introduc
twentyf
year
ago
wide
use
investig
proteinprotein
network
model
organ
pathogen
host
bacteria
yeast
fruit
fli
tumor
virus
host
herp
virus
host
huge
interactom
dataset
obtain
genomewid
yeast
twohybrid
screen
greatli
facilit
identif
crucial
protein
consid
druggabl
wide
distribut
host
protein
interact
virus
make
select
drug
target
multipl
host
target
difficult
enteroviru
neither
genomewid
rnai
screen
virushost
proteinprotein
interact
identif
explor
construct
protein
interact
network
integr
public
protein
drug
databas
verifi
protein
function
explor
potenti
serv
drug
target
predict
antivir
drug
fig
identifi
interact
protein
host
cellular
protein
use
yeast
twohybrid
screen
provid
network
view
infect
viral
orfeom
gener
includ
orf
encod
fulllength
matur
protein
sever
protein
domain
brcr
bait
sequenc
clone
fusion
vector
dna
bind
domain
bait
construct
screen
human
brain
cdna
librari
use
highli
stringent
assay
twentynin
protein
interact
identifi
analysi
integr
protein
interact
network
reveal
topolog
featur
human
protein
eip
function
pathway
relat
infect
overlap
analysi
eip
protein
interact
function
associ
virus
found
might
broadspectrum
essenti
host
factor
valid
essenti
infect
vitro
map
eip
known
drug
target
relat
drug
indic
mainli
cover
infectionrel
symptom
indic
potenti
eip
serv
hostdirect
antivir
target
use
connect
map
resourc
find
drug
inhibit
eip
help
valid
valu
eip
antivir
target
drug
tanespimycin
show
signific
inhibit
eip
express
significantli
inhibit
infect
vitro
map
protein
includ
cellular
protein
gener
screen
total
posit
coloni
obtain
coloni
ident
determin
dna
sequenc
fiftyeight
coloni
test
yeast
retransform
assay
final
posit
coloni
obtain
repres
uniqu
proteinprotein
interact
human
protein
provid
network
view
proteinprotein
interact
fig
virushost
protein
interact
identifi
intern
capsid
protein
two
nonstructur
protein
nonstructur
protein
interact
host
protein
fig
c
share
mani
five
human
protein
interact
protein
interact
three
viral
protein
use
david
onlin
tool
annot
cluster
eip
identifi
common
protein
characterist
supplementari
tabl
gene
encod
membran
protein
function
nerv
signal
transduct
pathway
four
enrich
annot
term
membran
protein
endoplasm
reticulum
hostviru
interact
glycoprotein
two
protein
involv
kegg
pathway
vesicular
transport
moreov
eighteen
eip
membran
protein
six
hostviru
interact
protein
eight
endoplasm
reticulum
protein
includ
seven
protein
locat
endoplasm
reticulum
membran
fig
supplementari
tabl
use
biolog
gener
repositori
interact
dataset
biogrid
databas
refer
construct
human
proteinprotein
interact
ppi
network
contain
nonredund
physic
ppi
human
protein
mani
twentyseven
eip
found
interact
human
protein
protein
togeth
anoth
protein
form
protein
interact
network
nonredund
physic
interact
fig
includ
interact
eip
ie
vapb
vapb
eip
selfprotein
interact
mff
defin
eip
togeth
eipinteract
protein
infectionassoci
human
protein
eap
investig
central
eip
human
ppi
network
ie
determin
whether
protein
tend
mostli
interact
act
bridg
protein
calcul
degre
between
central
averag
shortest
path
length
protein
human
ppi
network
includ
eip
fig
c
degre
equal
number
protein
direct
interact
given
protein
repres
local
central
shortest
path
two
protein
shortest
rout
contain
least
number
protein
interact
network
between
central
count
ratio
shortest
path
two
protein
network
pass
given
protein
repres
global
central
averag
degre
averag
shortest
path
averag
between
central
protein
human
ppi
network
respect
wherea
valu
eip
respect
fig
c
signific
differ
averag
degre
averag
between
central
eip
protein
test
use
twosid
wilcoxon
rank
sum
test
signific
level
p
respect
although
averag
shortest
path
length
significantli
differ
higher
degre
indic
eip
protein
interact
wherea
lower
between
central
indic
eip
central
global
function
analysi
protein
network
explor
eip
function
analyz
eip
enrich
signific
differ
pathway
reactom
pathway
databas
opensourc
peerreview
pathway
databas
provid
pathway
knowledg
analyz
pathway
enrich
eip
supplementari
tabl
unexpectedli
pathway
eip
enrich
decentr
two
protein
found
pathway
use
p
cutoff
nine
reactom
pathway
identifi
significantli
enrich
includ
neuron
system
pathway
botulinum
neurotox
snare
complexrel
pathway
metabol
pathway
serin
biosynthesi
glycerophospholipid
biosynthesi
extracellular
matrix
organ
pathway
elast
fiber
format
supplementari
tabl
due
small
number
eip
function
annot
enrich
analysi
provid
limit
inform
obtain
detail
function
annot
eap
use
analyz
enrich
signific
reactom
pathway
supplementari
tabl
nine
twentyfour
top
level
reactom
pathway
apoptosi
cell
cycl
diseas
dna
replic
gene
express
membran
traffick
metabol
immun
system
neuron
system
cover
significantli
enrich
reactom
pathway
p
supplementari
tabl
suggest
eap
function
variou
bioprocess
two
significantli
enrich
pathway
botulinum
neurotox
phase
shown
figur
due
differ
function
protein
host
protein
interact
differ
viral
protein
possibl
differ
bioprocess
pathway
divid
eap
four
group
accord
interact
viral
protein
analyz
enrich
reactom
pathway
supplementari
tabl
eap
associ
capsid
protein
enrich
pathway
mainli
tgfbetasmad
signal
pathway
supplementari
tabl
contrast
viral
proteinassoci
eap
involv
wide
distribut
pathway
includ
cell
cycl
phaserel
pathway
immun
systemrel
pathway
activ
nfkappa
b
b
cell
class
mhcmediat
antigen
process
present
inflammasom
signal
transduct
pathway
betacateninindepend
wnt
signal
mtor
signal
signal
neuron
system
pathway
neurotransmitt
releas
cycl
botulinum
neurotox
pathway
hiv
infect
ubiquitindepend
protein
interact
subnetwork
eap
orang
node
repres
eip
blue
node
repres
human
protein
interact
node
size
directli
proport
node
degre
subnetwork
b
c
degre
b
between
central
c
distribut
protein
red
point
eip
blue
point
human
proteinprotein
interact
network
p
k
repres
probabl
node
degre
k
p
b
repres
probabl
node
between
central
b
dash
line
repres
averag
degre
protein
red
eip
blue
averag
degre
between
central
shortest
path
eip
protein
tabl
pathway
also
close
interact
viral
protein
addit
eap
enrich
event
transmembran
transport
small
molecul
lysosom
vesicl
biogenesi
pathway
viral
protein
eap
involv
rel
fewer
type
pathway
primarili
includ
neuron
system
pathway
botulinum
neurotox
acetylcholin
neurotransmitt
releas
cycl
metabol
pathway
metabol
lipid
lipoprotein
supplementari
tabl
viral
protein
protein
neighbor
primarili
enrich
cellular
respons
stress
pathway
cellular
respons
hypoxia
cellular
senesc
supplementari
tabl
overlap
analysi
eip
virusinteract
protein
identifi
potenti
broadspectrum
antivir
target
rapid
growth
virushost
protein
interact
knowledg
hostviru
interact
regard
network
perspect
larg
number
systemat
valid
virushost
interact
serv
baselin
estim
valu
eip
viru
infect
common
experiment
method
systemat
identif
virusinteract
host
factor
primarili
identifi
viral
protein
physic
interact
host
protein
virustarget
protein
vtp
use
screen
essenti
host
factor
ehf
use
genomewid
rnai
screen
systemat
collect
virusprotein
physic
interact
rnai
screen
result
determin
whether
eip
also
function
viru
infect
twelv
eip
vtp
virus
supplementari
tabl
eip
ehf
virus
supplementari
tabl
present
eip
relationship
virus
network
perspect
fig
eip
known
physic
interact
virus
serv
ehf
virus
sort
five
categori
accord
interact
protein
fig
capsid
proteininteract
host
protein
like
known
vtp
half
capsidinteract
protein
known
vtp
indic
protein
univers
protein
viral
adhes
interestingli
protein
ehf
indic
increas
function
import
host
protein
vtp
granulin
encod
grn
gene
report
interact
mani
five
virus
report
interact
three
virus
due
rel
genomewid
rnai
screen
report
eip
report
ehf
one
viru
howev
ehf
two
five
differ
virus
respect
broad
relationship
differ
virus
indic
univers
import
function
differ
viru
infect
make
potenti
broadspectrum
host
target
antivir
therapi
therefor
valid
interact
protein
studi
function
infect
result
subcellular
coloc
cotransfect
rd
cell
show
coloc
primarili
cytoplasm
fig
addit
result
coimmunoprecipit
experi
indic
interact
protein
cotransfect
rd
cell
fig
studi
role
infect
sirna
use
downregul
gene
express
could
express
protein
cell
use
overexpress
result
show
sirna
target
inhibit
propag
fig
overexpress
cell
enhanc
propag
fig
bafilomycin
select
inhibitor
vacuolar
h
atpas
vatpas
studi
bafilomycin
use
studi
function
infect
rd
cell
infect
viru
presenc
vari
concentr
bafilomycin
nmoll
h
wash
three
time
pb
cell
cultur
fresh
growth
medium
addit
h
cell
cultur
collect
subject
plaqu
assay
result
show
bafilomycin
inhibit
infect
dosedepend
manner
fig
addit
vitro
cytotox
result
show
treatment
rd
cell
serial
bafilomycin
dilut
h
cytotox
determin
cellular
prolifer
rate
even
concentr
high
nm
fig
drug
predict
eip
high
overlap
rate
eip
virusinteract
protein
prove
reliabl
eip
possibl
use
broadspectrum
hostdepend
antivir
target
howev
whether
drug
target
could
effect
unknown
explor
potenti
use
protein
host
target
queri
drugbank
identifi
drug
target
contrari
mani
overlap
eip
vtp
ehf
eip
known
drug
target
eip
target
drug
nadh
target
phgdh
stannsoporfin
target
nadh
endogen
small
molecul
particip
citric
acid
cycl
cellular
respir
mani
protein
record
target
nadh
make
phgdh
nonspecif
endogen
charact
nonspecif
target
made
nadh
unsuit
drug
candid
moreov
stannsoporfin
fail
inhibit
infect
vitro
obtain
drug
candid
list
drug
target
eap
supplementari
tabl
drug
candid
increas
eip
neighbor
consid
drug
interact
differ
target
interact
type
drug
properti
drug
type
categori
anatom
therapeut
chemic
atc
code
also
list
supplementari
tabl
enrich
analysi
drug
properti
could
help
determin
drug
characterist
tendenc
eap
function
featur
list
enrich
p
drug
properti
tabl
detail
supplementari
tabl
enrich
drug
type
divers
includ
approv
psychotrop
neurolog
drug
betablock
agent
glucocorticoid
antiinflammatori
agent
drug
primarili
relat
inflamm
control
neurolog
indic
relat
infect
symptom
drugtarget
interact
type
also
count
analyz
inhibitor
agonist
neg
modul
type
enrich
p
drugtarget
interact
type
supplementari
tabl
e
inhibit
replic
bafilomycin
rd
cell
infect
viru
presenc
vari
concentr
bafilomycin
nmoll
h
wash
cell
cultur
fresh
growth
mediumfor
addit
h
cell
cultur
subject
plaqu
assay
compar
viru
control
p
p
n
f
cytotox
bafilomycin
percent
viabil
rd
cell
determin
normal
absorb
nm
drugfre
cultur
g
inhibit
propag
sirna
h
increas
propag
rd
cell
transfect
sirna
subsequ
infect
h
later
viru
rna
cell
cultur
isol
subject
real
time
rtpcr
viru
growth
shown
averag
percentag
rel
control
cell
infect
p
n
although
targetassoci
strategi
provid
suffici
hostori
drug
candid
candid
usual
target
one
two
protein
directli
target
eip
thu
one
one
valid
antivir
activ
would
difficult
ideal
would
like
identifi
drug
inhibit
eip
block
hostviru
interact
connect
map
gene
set
enrich
analysi
gsea
provid
applic
strategi
evalu
drug
influenc
group
target
ie
signatur
express
profil
pair
express
profil
repres
cellular
respons
differ
drug
arrang
gene
rank
list
connect
map
gene
rank
express
chang
due
drug
interfer
ie
gene
upregul
drug
interfer
place
top
rank
list
downregul
gene
place
bottom
gsea
base
kolmogorovsmirnov
ks
statist
use
estim
whether
group
target
ie
signatur
tend
appear
top
bottom
gene
rank
list
determin
whether
signatur
univers
regul
drug
interfer
enrich
score
acquir
gsea
rang
neg
score
indic
inhibit
signatur
posit
score
indic
activ
signatur
use
eip
signatur
attempt
find
drug
inhibit
drug
interfer
experi
sort
correspond
enrich
score
eip
ascend
order
ie
toprank
drug
interfer
experi
tend
inhibit
eip
experi
use
drug
check
determin
whether
consist
toprank
permut
p
valu
estim
random
rank
experi
baselin
use
describ
signific
drug
inhibit
eip
use
permut
p
cut
drug
identifi
significantli
inhibit
eip
express
supplementari
tabl
toprank
drug
tanespimycin
chosen
evalu
detect
antivir
activ
result
shown
fig
tanespimycin
significantli
inhibit
virusinduc
cytopath
effect
cpe
concentr
valid
activ
tanespimycin
cc
ec
tanespimycin
calcul
fig
c
figur
show
cytox
tanespimycin
rd
cell
cc
calcul
assess
antivir
activ
rd
cell
infect
hour
follow
addit
serial
dilut
tanespimycin
hour
virusinduc
cpe
detect
use
assay
cell
cultur
collect
viral
rna
isol
detect
rna
use
realtim
rtpcr
result
shown
fig
c
tanespimycin
inhibit
virusinduc
cpe
viral
rna
level
dosedepend
manner
ec
cpe
inhibit
nm
protein
interact
network
gener
collect
host
protein
interact
viral
protein
identifi
potenti
associ
viru
prolifer
virusinduc
cytotox
host
defens
escap
hostviru
interact
find
potenti
therapi
block
hostviru
interact
function
associ
analysi
eip
provid
hypothesi
infectiondepend
pathway
potenti
therapi
howev
whether
interact
function
influenc
requir
valid
result
provid
initi
start
point
complex
system
analysi
infect
obtain
systemat
understand
viru
infect
depend
confirm
compon
integr
inform
entir
cellular
function
network
result
agre
known
knowledg
infect
instanc
role
kegg
pathway
vesicular
transport
interact
protein
agre
find
promot
vesicular
transport
viru
infect
viral
protein
interact
human
protein
high
local
global
central
high
local
global
central
human
protein
indic
protein
tend
interact
protein
larger
influenc
signal
transfer
throughout
human
protein
interact
network
respect
literatur
analysi
indic
tendenc
viral
protein
interact
central
protein
might
gener
hallmark
viral
protein
low
global
central
indic
rel
weak
influenc
eip
whole
human
protein
interact
network
might
result
limit
tissuespecif
protein
librari
use
studi
function
analysi
eip
neighbor
protein
reveal
major
function
like
perturb
viral
protein
infect
function
includ
cell
cycl
apoptosi
multipl
signal
transfer
pathway
immun
system
neuron
system
pathway
pathway
cell
cycl
apoptosisrel
pathway
close
relat
viru
prolifer
transmiss
pathway
botulinum
neurotox
inflammasom
immun
system
pathway
might
play
import
role
acut
infect
symptom
result
provid
insight
investig
hostviru
interact
suggest
protein
directli
interact
virus
could
essenti
viru
replic
diseas
progress
thu
serv
potenti
antivir
target
investig
potenti
eip
drug
reposit
explor
associ
eip
virus
result
suggest
half
eip
known
interact
virus
indic
potenti
serv
broadspectrum
target
outstand
eip
ie
also
ehf
five
differ
virus
vitro
valid
influenc
infect
report
demonstr
essenti
subunit
c
vatpas
report
shown
vatpas
essenti
entri
mani
virus
includ
influenza
viru
human
cytomegaloviru
west
nile
viru
polio
viru
sindbi
viru
accord
role
vatpas
viru
infect
result
specul
possibl
mechan
facilit
infect
might
via
effect
entri
cell
associ
eip
drug
could
help
elucid
hostori
antivir
potenti
known
drug
approv
drug
significantli
outnumb
enrich
analysi
targetdriven
drug
candid
suggest
safe
conveni
drug
reposit
although
signific
may
result
knowledg
bia
psychotrop
neurolog
drug
enrich
due
outnumb
drug
target
neural
protein
eap
drug
properti
betablock
agent
glucocorticoid
antiinflammatori
agent
indic
possibl
adjuv
drug
infect
despit
mass
indirect
targetdriven
drug
candid
safe
drug
directli
target
eip
drug
affect
larg
number
target
specif
targetdriven
drug
candid
differ
drug
mani
target
like
elect
candid
eip
phgdh
target
nadh
consid
fact
nadh
affect
hundr
target
dozen
pathway
probabl
fals
posit
predict
attempt
use
connect
map
anoth
power
strategi
drug
reposit
predict
drug
candid
principl
drug
candid
tend
inhibit
eip
gene
express
vitro
valid
tanespimycin
inhibit
cpe
support
strategi
five
highrank
drug
fail
reduc
cpe
fuction
import
eip
differ
mere
assess
overal
express
level
eip
practic
loos
better
approach
identifi
function
role
eip
find
drug
exactli
modul
key
eip
make
like
find
effect
drug
promin
advantag
hosttarget
antivir
strategi
host
cell
provid
much
broader
target
drug
candid
viru
moreov
due
mutat
rate
human
gene
far
lower
viral
gene
hosttarget
strategi
also
better
solv
problem
drug
resist
addit
host
protein
may
pivot
varieti
virus
therefor
hosttarget
drug
may
broadspectrum
antivir
activ
despit
benefit
hosttarget
antivir
strategi
current
therapeut
drug
viral
diseas
mainli
target
viral
compon
especi
viral
enzym
viral
protein
interact
host
factor
promot
viral
replic
diseas
process
systemat
experiment
identif
virusinteract
host
factor
bioinformat
method
use
build
virushost
interactom
predict
therapeut
target
although
approach
still
infanc
antivir
molecul
reduc
safeti
risk
low
resist
induct
predict
valid
studi
public
databas
use
function
annot
eip
find
eip
therapeut
valu
two
drug
reposit
strategi
use
predict
antivir
drug
though
imperfect
studi
provid
pipelin
virushost
interact
network
therapeut
applic
accumul
share
virushost
interactom
data
progress
system
biolog
hosttarget
antivir
drug
aris
total
rna
revers
transcrib
cdna
use
superscript
iii
firststrand
synthesi
system
invitrogen
california
usa
accord
manufactur
instruct
clone
pcr
amplif
gene
product
frame
cdna
subject
pcr
amplif
use
pair
primer
adapt
contain
restrict
site
appropri
posit
digest
correspond
restrict
enzym
dna
fragment
pdbleu
plasmid
ad
ligat
reaction
mixtur
ligat
reaction
incub
overnight
use
directli
bacteri
transform
identifi
confirm
orf
entri
clone
pcr
perform
follow
sequenc
plasmid
yeast
twohybrid
screen
bait
plasmid
transform
yeast
strain
matchmak
yeast
transform
system
clontech
test
autoactiv
bait
yeast
select
minim
medium
bait
construct
without
selfactiv
screen
adult
brain
cdna
librari
posit
coloni
grew
select
plate
pick
prey
plasmid
isol
transform
e
coli
plasmid
retest
transform
viral
bait
yeast
ident
posit
coloni
identifi
dna
sequenc
interact
databas
http
thebiogridorgvers
compil
septemb
physic
interact
human
protein
filter
serv
human
ppi
baselin
map
protein
hprd
proteinprotein
interact
network
obtain
physic
interact
protein
neighbor
human
ppi
network
use
complex
network
packag
version
selfemerg
knowledg
tree
extract
wikipedia
hierarchi
perform
topolog
analysi
degre
protein
node
equal
ppi
interact
incid
node
whole
network
degre
distribut
eip
compar
degre
distribut
whole
human
protein
shortest
path
path
two
protein
count
edg
path
minim
shortest
path
length
equal
edg
count
shortest
path
thu
number
shortest
path
two
differ
node
b
express
n
ab
number
shortest
path
b
pass
node
c
express
n
ab
c
between
central
c
express
follow
annot
cluster
david
onlin
tool
databas
annot
visual
integr
discoveri
david
version
use
annot
eip
eip
submit
david
tool
human
protein
use
baselin
function
eip
cluster
default
set
use
paramet
annot
categori
annot
cluster
result
manual
check
determin
outstand
characterist
eip
eip
graphic
present
venn
diagram
accord
main
characterist
reactom
pathway
enrich
analysi
cytoscap
plugin
reactom
fi
version
use
analyz
pathway
enrich
signific
visual
eap
pathway
reactom
pathway
load
cytoscap
eap
independ
viral
proteininteract
protein
arrang
separ
gene
set
gene
set
load
analyz
pathway
enrich
enrich
p
valu
fals
discoveri
rate
pathway
provid
reactom
fi
pathway
enrich
p
valu
less
use
collect
viral
physic
interact
protein
enrich
analysi
drug
properti
drug
properti
interest
includ
drug
type
small
molecul
biotech
drug
group
approv
inform
drug
categori
atc
code
briefli
atc
code
level
use
repres
drug
atc
characterist
use
drug
drugbank
background
enrich
signific
drug
properti
evalu
hypergeometr
distribut
suppos
total
drug
number
drugbank
n
total
drug
candid
number
n
k
total
drug
character
characterist
x
k
drug
candid
character
x
enrich
p
valu
characterist
x
express
follow
enrich
analysi
drugtarget
action
similar
enrich
analysi
drug
properti
drugtarget
action
type
drug
candid
total
drug
analyz
suppos
number
drugtarget
action
total
drug
n
correspond
number
drug
candid
n
k
n
action
action
type
x
k
n
action
type
action
type
enrich
signific
drug
candid
express
enrich
p
valu
list
cell
viru
compound
rhabdomyosarcoma
rd
cell
american
type
cultur
collect
atcc
vero
cell
atcc
frequent
use
isol
clinic
specimen
highli
suscept
cell
routin
grown
dulbecco
modifi
eagl
medium
high
glucos
dmem
gibco
grand
island
ny
usa
supplement
fetal
calf
serum
fc
brcr
strain
propag
rd
cell
titrat
tissu
cultur
infect
dose
assay
compound
purchas
sigmaaldrich
sigmaaldrich
st
loui
mo
usa
dissolv
water
mm
dmso
accord
solubl
compound
final
dmso
concentr
cultur
medium
exceed
antivir
effect
sens
sequenc
sirna
cagccacagaauauuauguaatt
synthes
shanghai
genepharma
co
ltd
sens
sequenc
neg
control
sirna
nc
sirna
uucuccgaacgugucacgutt
doublelabel
immunofluoresc
assay
rd
cell
cultur
glass
cover
slip
bottom
cell
cultur
dish
h
posttransfect
cell
fix
minut
paraformaldehyd
prepar
pb
permeabil
triton
pb
minut
wash
time
pb
incub
room
temperatur
min
block
buffer
bsapb
cell
incub
primari
antibodi
antiha
antimyc
h
wash
time
pb
room
temperatur
incub
secondari
antibodi
antirabbit
antimous
iggtritc
h
cell
counterstain
dapi
visual
confoc
laser
scan
microscopi
olympu
fluoview
japan
trishcl
buffer
ph
contain
proteinas
inhibitor
cocktail
roch
indianapoli
mm
nacl
sodium
deoxychol
cell
lysat
incub
antimyc
monoclon
antibodi
cell
signal
technolog
overnight
rotat
sampl
incub
protein
ag
agaros
bead
santa
cruz
biotechnolog
santa
cruz
ca
h
rotat
wash
time
trishcl
buffer
immunocomplex
captur
protein
ag
agaros
bead
boil
min
resolv
sdspolyacrylamid
gel
electrophoresi
separ
protein
transfer
pvdf
membran
millipor
bedford
usa
membran
incub
overnight
antiha
antimyc
antibodi
wash
membran
incub
horseradish
peroxidaseconjug
secondari
antibodi
h
room
temperatur
final
membran
incub
enhanc
chemiluminesc
ecl
reagent
millipor
expos
autoradiographi
film
dark
compound
treatment
infect
cell
tissu
cultur
rd
cell
seed
plate
twentyfour
hour
later
cell
infect
multipl
infect
moi
h
medium
replac
mainten
medium
contain
fc
serial
dilut
compound
fortyeight
hour
later
cell
observ
virusinduc
cytopath
effect
cpe
supernat
collect
detect
rna
plaqu
assay
cell
prolifer
viabil
assay
patholog
chang
cell
infect
observ
use
invert
microscop
olympu
cell
viabil
test
use
cell
count
dojindo
laboratori
kumamoto
japan
cpe
inhibit
data
calcul
accord
absorb
measur
nm
micropl
reader
model
biorad
hercul
ca
usa
express
effect
viral
cpe
inhibitori
concentr
ec
experi
perform
triplic
repeat
three
time
plaqu
assay
monolay
vero
cell
per
well
seed
plate
h
cultur
cell
inocul
dilut
viral
suspens
h
cell
wash
pb
overlaid
warm
methyl
cellulos
mc
sigma
usa
mem
incub
day
cell
fix
formaldehyd
h
mc
wash
subsequ
stain
crystal
violet
viru
titer
express
plaqueform
unit
pfu
per
ml
realtim
revers
transcript
rt
pcr
detect
rna
viral
rna
isol
cell
supernat
use
rneasi
mini
kit
qiagen
hilden
germani
realtim
rtpcr
perform
use
quant
one
step
qrtpcr
probe
kit
tiangen
primer
probe
previous
report
forward
fp
revers
rp
primer
nt
nt
respect
probe
nt
absolut
quantif
viral
rna
perform
use
standard
curv
scientif
report
doi
vitro
cytotox
assay
cytotox
compound
rd
cell
evalu
cytotox
concentr
cc
briefli
monolay
cultur
rd
cell
expos
sever
concentr
compound
mainten
medium
fc
day
cell
viabil
assay
use
method
follow
manufactur
instruct
experi
perform
triplic
repeat
three
time
